📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Arvelle Therapeutics

1.1 - Company Overview

Arvelle Therapeutics Logo

Arvelle Therapeutics

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative biopharmaceutical solutions for patients suffering from central nervous system (CNS) disorders.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Arvelle Therapeutics

Mika Pharma Logo

Mika Pharma

HQ: Germany Website
  • Description: Provider of innovative drug delivery technologies for pharmaceuticals, developing, producing, and selling dermal, transdermal, and buccal application systems based on sprayable liposomes, pre-liposomal solutions, and proprietary micellar solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mika Pharma company profile →
Oscine Therapeutics Logo

Oscine Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology innovations based on discoveries made and developed at the University of Rochester Medical Center.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oscine Therapeutics company profile →
Aderis Pharmaceuticals Logo

Aderis Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical products for the diagnosis and treatment of cardio-renal and cardiovascular diseases, including adenosine agonists and antagonists; focused on discovery, development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aderis Pharmaceuticals company profile →
Arcion Therapeutics Logo

Arcion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on developing treatments for chronic pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arcion Therapeutics company profile →
Concentric Medical Logo

Concentric Medical

HQ: United States Website
  • Description: Provider of minimally invasive medical devices for use in the neurovasculature, focusing on the design, development, and commercialization of these technologies; headquartered in Mountain View, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Concentric Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Arvelle Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Arvelle Therapeutics

2.2 - Growth funds investing in similar companies to Arvelle Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Arvelle Therapeutics

4.2 - Public trading comparable groups for Arvelle Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Arvelle Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Arvelle Therapeutics

What does Arvelle Therapeutics do?

Arvelle Therapeutics is a provider of innovative biopharmaceutical solutions for patients suffering from central nervous system (CNS) disorders.

Who are Arvelle Therapeutics's competitors?

Arvelle Therapeutics's competitors and similar companies include Mika Pharma, Oscine Therapeutics, Aderis Pharmaceuticals, Arcion Therapeutics, and Concentric Medical.

Where is Arvelle Therapeutics headquartered?

Arvelle Therapeutics is headquartered in Switzerland.

How many employees does Arvelle Therapeutics have?

Arvelle Therapeutics has 1,000 employees 🔒.

When was Arvelle Therapeutics founded?

Arvelle Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Arvelle Therapeutics in?

Arvelle Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Arvelle Therapeutics

Who are the top strategic acquirers in Arvelle Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Arvelle Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Arvelle Therapeutics?

Top strategic M&A buyers groups and sectors for Arvelle Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Arvelle Therapeutics's sector and industry vertical

Which are the top PE firms investing in Arvelle Therapeutics's sector and industry vertical?

Top PE firms investing in Arvelle Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Arvelle Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Arvelle Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Arvelle Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Arvelle Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Arvelle Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Arvelle Therapeutics?

The key public trading comparables and valuation benchmarks for Arvelle Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Arvelle Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Arvelle Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Arvelle Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Arvelle Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Arvelle Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Arvelle Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Arvelle Therapeutics